Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib-effective patients with advanced NSCLC
/in Hyperthermia, International Publications, NSCLC /von 2016-03-24 / Thorac Cancer 2016 Jul;7(4):422-7Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2016-03-04 / Cancer Sci. 2016 Apr;107(4):514-20Hyperthermia: How Can It Be Used?
/in Hyperthermia, International Publications /von 2016-03-01 / Oman Med J 2016 Mar;31(2):89-97Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination
/in Dendritic Cells, Hyperthermia, International Publications /von 2016-01-22 / J. Exp. Clin. Cancer Res. 2016 Jan;35:18Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
/in Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen /von 2016-01-14 / Front Immunol 2015;6:663Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2016-01-11 / Int J Hyperthermia 2016;32(2):187-92Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis
/in Breast Cancer, Hyperthermia, International Publications /von 2015-12-21 / Int. J. Radiat. Oncol. Biol. Phys. 2016 Apr;94(5):1073-87Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters
/in Breast Cancer, Hyperthermia, International Publications /von 2015-11-02 / Radiother Oncol 2015 Nov;117(2):223-8Hyperthermia: an effective strategy to induce apoptosis in cancer cells
/in Hyperthermia, International Publications /von 2015-11-01 / Apoptosis 2015 Nov;20(11):1411-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de